SVA

Sinovac Biotech, Ltd

Delisted

SVA was delisted on the 22nd of February, 2019.

40 hedge funds and large institutions have $72.5M invested in Sinovac Biotech, Ltd in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1K
Puts
$2K
Net Calls
Net Calls Change

Top Buyers

1 +$3.7M
2 +$1.36M
3 +$351K
4
Two Sigma Investments
Two Sigma Investments
New York
+$279K
5
GC
Guggenheim Capital
Illinois
+$167K

Top Sellers

1 -$4.08M
2 -$2.67M
3 -$802K
4
ProShare Advisors
ProShare Advisors
Maryland
-$216K
5
Millennium Management
Millennium Management
New York
-$80.3K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$29.9M
2
$15.3M
3
$7.75M
4
$6.24M
5
$5.9M
6
$1.75M
7
$1.38M
8
$833K
9
$610K
10
$434K
11
$421K
12
$417K
13
$264K
14
$167K
15
$151K
16
$142K
17
$133K
18
$92K
19
$82K
20
$79K
21
$75K
22
$63K
23
$62K
24
$58K
25
$57K